Siemens Healthineers closes Fast Track Diagnostics buy

Siemens (NYSE:SI) Healthineers said today it completed its acquisition of Fast Track Diagnostics, marking the official date of the closing as December 19, 2017. With the acquisition, FTD’s sites in Luxembourg, Malta and India and its approximately 80 employee workforce will be folded into Siemens Healthineers business. FTD produces a range of CE Mark approved infectious disease detection tests and syndromic panels, and will continue to operate under the brand name Fast Track Diagnostics, Siemens said. “The closing of this deal enables both Siemens Healthineers and FTD—now joined as one—to more effectively address the evolving needs of the molecular diagnostics marketplace. It is an exciting time for us at Siemens Healthineers as we welcome the FTD community into our own,” Siemens molecular diagnostics head Fernando Beils said in a press release. Terms of the deal were not disclosed by Siemens. Last month, Siemens said it launched the Cardio dashboard application in its Siemens Healthineers cloud-based network of applications. The post Siemens Healthineers closes Fast Track Diagnostics buy appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Diagnostics Mergers & Acquisitions Siemens Source Type: news